0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Relationship Between Postmenopausal Hormone Replacement Therapy and Ovarian Cancer

Enrique Hernandez, MD
JAMA. 2001;285(24):3089-3090. doi:10.1001/jama.285.24.3089.
Text Size: A A A
Published online

Extract

To the Editor: Dr Rodriguez and colleagues1 suggest that if others confirm their findings, a possible increase in risk of dying from ovarian cancer should be added to the list of possible estrogen-related adverse effects to be discussed with patients considering HRT. They based this recommendation on finding that 31 women died from ovarian cancer among women who in 1982 self-reported using HRT for 10 years or more. This is a relatively small number of events, which weakens the reliability of the conclusions. In addition, other reports on the effect of HRT use on ovarian cancer risk are inconsistent. Of the 5 case-control studies cited by Rodriguez et al that measured ovarian cancer risk among women who used HRT for 5 or more years, 4 found no statistically significant difference.24 One study found a statistically significant increased risk of endometrioid ovarian adenocarcinoma among women who used unopposed estrogen (OR, 2.81; 95% CI, 1.15-6.89).5 For the more common serous carcinomas, the OR of 2.03 was barely statistically significant (95% CI, 1.04-3.97). A recent meta-analysis reported no association between HRT use and ovarian cancer.6

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 18

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();